Journal for ImmunoTherapy of Cancer (May 2022)
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients
- Gennaro Ciliberto,
- Luigi Aurisicchio,
- Matteo Pallocca,
- Maria Laura Foddai,
- Christian Napoli,
- Maurizio Fanciulli,
- Francesca De Nicola,
- Federico Venuta,
- Sara Bruschini,
- Eleonora Sperandio,
- Lorenzo D’Ambrosio,
- Francesca Ascenzi,
- Claudia De Vitis,
- Valentina Salvati,
- Antonella Esposito,
- Simona Di Martino,
- Francesca Paolini,
- Luigi Fattore,
- Gabriele Alessandrini,
- Francesco Facciolo,
- Massimiliano Bassi,
- Michela D’Ascanio,
- Alberto Ricci,
- Antonio D’ Andrilli,
- Erino Angelo Rendina,
- Rita Mancini
Affiliations
- Gennaro Ciliberto
- Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Luigi Aurisicchio
- Aff5 Takis Rome Italy
- Matteo Pallocca
- 5 SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Maria Laura Foddai
- Immunohematology and Transfusional Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Christian Napoli
- 4 Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, Roma, Lazio, Italy
- Maurizio Fanciulli
- SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, Istituto Regina Elena Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, Italy
- Francesca De Nicola
- 4 SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Federico Venuta
- 1Department of Thoracic Surgery, University of Rome Sapienza, Rome, Italy
- Sara Bruschini
- Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy
- Eleonora Sperandio
- Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Lorenzo D’Ambrosio
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Francesca Ascenzi
- Department of Clinical and Molecular Medicine, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- Claudia De Vitis
- Department of Clinical and Molecular Medicine, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- Valentina Salvati
- Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Antonella Esposito
- Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy
- Simona Di Martino
- Pathology Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy
- Francesca Paolini
- Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Luigi Fattore
- SAFU Laboratory, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Gabriele Alessandrini
- Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Francesco Facciolo
- Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Massimiliano Bassi
- Thoracic Surgery Unit, Sapienza University of Rome, Rome, Italy
- Michela D’Ascanio
- Department of Clinical and Molecular Medicine, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- Alberto Ricci
- Department of Clinical and Molecular Medicine, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- Antonio D’ Andrilli
- Thoracic Surgery Unit, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- Erino Angelo Rendina
- Thoracic Surgery Unit, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- Rita Mancini
- Department of Clinical and Molecular Medicine, Sant` Andrea Hospital-Sapienza University of Rome, Rome, Italy
- DOI
- https://doi.org/10.1136/jitc-2021-004239
- Journal volume & issue
-
Vol. 10,
no. 5
Abstract
No abstracts available.